Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE THE UNITED STATES EDITION 2026

the United States’s
wearables industry,
in focus.

The companies, capital and talent shaping wearables in the United States. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Wearables Industry Landscape of the United States
US
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Wearables illustration
MEET THE COMPANIES

Explore the United States’s wearables leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Wearables company highlights in the United States, snapshot 30 August 2026
Company
Jawbonejawbone.com$1.27B50
Whoopwhoop.com$979.39M11 roles453
ROM Technologiesromtech.com$532.81M206
Earlens Corporationearlens.com$435.04M129
Cala Healthcalahealth.com$307.05M50
BrainCobrainco.tech$291.8M40
Willowonewillow.com$228.11M109
Ceribellceribell.com$207.52M10 roles218$89.06MFYFY2025 filing
HearUSAhearusa.com12 roles497
Medical Guardianmedicalguardian.com12 roles178
Sleep Numbersleepnumber.com11 roles2,328$1.68BFYFY2024 filing
Garmin Internationalgarmin.com9 roles19,900$7.25BFYFY2025 filing
Lucid Hearinglucidhearing.com7 roles
AlignMedalignmed.com6 roles9
Amazfitamazfit.com9
Audicusaudicus.com58Financial figure available in RadarView in Radar
AvaSureavasure.com186
Biotricitybiotricity.com55$13.79MFYFY2025 filing
Carbinoxshopcarbinox.com
Cloudclouddx.com55Financial figure available in RadarView in Radar
Hapbeehapbee.com
IBSibs.inc26Financial figure available in RadarView in Radar
Sonicsonici.com6,953$15.15BFYFY2025 filing
Stravastrava.com290
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Wearables industry KPIs in the United States

A few useful ratios bring the size of this ecosystem into perspective.

30 August 2026
Hiring participation4.4%

63 of 1,444 tracked companies have open roles.

Funding participation34.3%

495 of 1,444 tracked companies have a recorded round.

Top 3 funding share25.2%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$1.51M

Midpoint of 926 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 25.2% of disclosed capital, while 65.7% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How the United States wearables has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

the United States wearables
$0$250.93M$501.86M$752.79M$1B2016: $651.76M20162017: $502.23M20172018: $768.25M20182019: $518.5M20192020: $880.46M20202021: $851.08M20212022: $527.38M20222023: $483.45M20232024: $532.81M20242025: $396.48M2025
View the numbers
Annual wearables funding and company formation in the United States
YearFunding (USD)FoundedRaising
2016$651.76M11988
2017$502.23M10583
2018$768.25M9295
2019$518.5M10482
2020$880.46M10973
2021$851.08M5374
2022$527.38M4971
2023$483.45M3167
2024$532.81M1654
2025$396.48M748
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Jawbone11.5%
  • Whoop8.9%
  • ROM Technologies4.8%
  • Other companies74.8%

Funding by stage

1,073 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel393 36.6%
Series A–B253 23.6%
Series C+ / PE94 8.8%
Grants, debt & other333 31.0%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Seed04/2026
Betterness $2.5M

Backed by Carlos Domingo and David Garcia and others.

Series G03/2026
Whoop $575M

Backed by Collab Fund and 2PointZero and others.

Series A03/2026
Stream $23M

Backed by Adjacent and Kindred Ventures.

Seed03/2026
Taya $5M

Backed by MaC Venture Capital and Female Founders Fund and others.

Angel02/2026
Pro2col $7.57M

Backed by Cristiano Ronaldo.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series G03/2026
Whoopwhoop.com$575M

Backed by Collab Fund and 2PointZero and others.

Series F08/2021
Whoopwhoop.com$200M

Backed by SoftBank Vision Fund and CAVU Consumer Partners and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
USD · millions · consolidated

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2025 · company accounts; aggregate reporting threshold not met · 7 reporting entities from 12 eligible matches.

Revenue in covered accounts

Sum of reporting-entity revenue; not the United States market sales.

Net profit / loss

Combined result for the same cohort.

Aggregate net margin

Combined net income ÷ combined revenue.

Median company revenue

The middle covered reporting entity.

Profitable entities

None of 7 covered entities.

Top-five concentration

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2025 · 7 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

7 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
THE UNITED STATES · INDUSTRY COHORTS

How does wearables compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the the United States companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Busiest websites

30 of the 1,444 companies on this page carry a measured traffic record (2.1%); these are the largest of those, by monthly visits. The median among them is 203,393 visits.

CompanyMonthly visitsAuthorityMobile
Stravastrava.com32,657,3877137.3%
Fitbitfitbit.com6,099,3245991.5%
Whoopwhoop.com5,245,7266970.1%
Amazfitamazfit.com1,931,3266067.8%
Razerzonerazerzone.com986,150448.7%
Glowglowing.com976,3995691.6%
Nanitnanit.com624,1834681.7%
Zepp Labszepp.com462,7833973.9%
Miracle-Earmiracle-ear.com426,4194989%
Pacermypacer.com400,4414682.3%

Visits and authority are third-party web estimates, not company-reported figures.

Most-installed apps

286 of these companies (19.8%) publish at least one Android app — 445 apps in all, carrying 411.7M installs between them.

AppInstallsRatingStore category
Strava: Run, Bike, WalkStrava124.3M4.6Health & Fitness
Garmin Connect™Garmin International49.3M4.3Health & Fitness
Pacer Pedometer & Step CounterPacer39.1M4.8Health & Fitness
ZeppZepp Labs37.9M4.4Sports
ASICS Runkeeper: Fitness AppRunkeeper36M4.7Health & Fitness
Connect IQ™ StoreGarmin International17.8M4.8Tools
C25K® Couch to 5K: Run TrainerC25K8.4M4.6Health & Fitness
Accupedo PedometerAccupedo8M3.8Health & Fitness
Welltory: Heart Rate MonitorWelltory5.7M4.6Health & Fitness
GOQii - Preventive Healthcare.Goqii5.5M3.8Health & Fitness

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Fitness & Wellness Tech226384.7MStrava: Run, Bike, Walk 124.3M
Wearable Technology347173.6MGarmin Connect™ 49.3M
Sports Tech27128.4MRide with GPS: Bike Navigation 2.6M
Disease Self Management15731.7MWelltory: Heart Rate Monitor 5.7M
Online Mom & Baby Care2015.5MOvulation Tracker App | Glow 3.6M
Consumer Electronics E-Commerce3112.8MGOQii - Preventive Healthcare. 5.5M
Hrtech119.5MOvia Cycle & Pregnancy Tracker 3M
Employee Health It99.4MOvia Parenting & Baby Tracker 880.2K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2023Q2: 112023Q2: 42023Q22023Q3: 62023Q3: 52023Q32023Q4: 82023Q4: 92023Q42024Q1: 122024Q1: 122024Q12024Q2: 92024Q2: 22024Q22024Q3: 92024Q3: 182024Q32024Q4: 92024Q4: 152024Q42025Q1: 102025Q1: 152025Q12025Q2: 112025Q2: 92025Q22025Q3: 102025Q3: 352025Q32025Q4: 112025Q4: 552025Q42026Q1: 202026Q1: 682026Q1

Darker bars are new releases, lighter bars apps updated. 435 of 445 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The the United States wearables market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Healthtech1,217
Consumer digital1,107
Iot in healthcare879
Consumer internet of things766
Medical devices670
Enterprise tech533
Non-invasive health monitoring devices422
Chronic disease management395
Hospital at home326
Iot in retail313
Life sciences301
Fitness and diet apps299

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Healthtech

The largest measured segment in this report snapshot.

1217companies
4.7%have hiring activity

57 companies hiring · $10.14B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Subscription968
E-commerce - product427
Physical commerce341
Commission on transaction71
Advertising45
Fee-for-service43
E-commerce - service26
Sponsorship5
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundscrosbytech.io ↗

Crosby has now raised a total of $85.8M in total equity funding and is backed by 01 Advisors, Bain Capital Ventures, Elad Gil, Index Ventures, and Lux Capital.

Funding roundswhoop.com ↗

WHOOP has now raised a total of $979M in total equity funding and is backed by 2PointZero, Abbott, Accomplice, Affinity Partners, and B-FLEXION.

Funding roundsjunebrain.com ↗

JuneBrain recently secured a joint investment from The New Orleans BioFund and the Gulf South Angels (GSA).

Funding roundsesperbionics.com ↗

One of the standout healthtech deals was Esper Bionics, which secured $5 million in a round led by YZR Capital.

Mergers & acquisitionssleepnumber.com ↗

Travis Kelce, a player in the US football team, Kansas City Chiefs, has just become a relevant shareholder in Sleep Number Corporation, a company listed at Nasdaq, acquiring 5% stake.

IPO activitystrava.com ↗

Strava has filed confidential paperwork for a US IPO, and it’s doing it with some momentum.

Funding roundsbrainco.tech ↗

China & Harvard Innovation Labs-incubated brainwave technology company BrainCo has raised $286 million (CNY 2 billion) in new funding round.

Funding roundshbox.ai ↗

BOSTON–(BUSINESS WIRE)–HBox (“HBox” or the “Company”), a leading virtual care platform for specialty practices, announced that it has received a growth investment from Charlesbank’s Technology Opportunities Fund (“TOF”) II.

Funding roundsibs.inc ↗

Intelligent Bio Solutions (INBS) stock dove on Friday after the biotechnology company announced a private placement with institutional investors. This $10 million private placement includes units with 2,298,850 shares of INBS stock, Series K-1 warrants to purchase another 2,298,850 shares, and Series K-2 warrants to purchase an additional 2,298,850 shares.

Funding roundsaltis.ai ↗

Rounding out the week, Brazil’s Altis raised $10 million through a Credit Rights Investment Fund (FIDC) structured by Galapagos Capital to expand its credit-as-a-service platform.

Full recorded event mix

Top 10 categories among 380 recorded events in the 24-month window.

Leadership moves
83
Earnings
83
Funding rounds
64
Mergers & acquisitions
36
Company announcements
25
New products
18
Board Updates
17
IPO activity
15
Capital infusions
8
Job creation
8
7 activity cards

Swipe or scroll horizontally to browse.

IPO pipeline

4 companies with recorded IPO activity

Strava ↗

IPO · US3 reports

Ceribell ↗

IPO · NASDAQ10 reports

IBS ↗

Follow-on Offering · NASDAQ1 reports

CardioNet ↗

IPO · Nasdaq Global Market2 reports

Leadership moves

18 tracked people moves

BRIAN REAGAN

Appointment Chief Commercial Officer

Token ↗
Katy Nelson

Appointment Chief Revenue Officer

Amy O’Keefe

Appointment Executive Vice President and Chief Financial Officer

Versus ↗
Michele Fino

Appointment Head of Content Partnerships

Dr. Douglas Casa

Appointment Scientific Advisor

Dr. Elaine Choung-Hee Lee

Appointment Scientific Advisor

Hapbee ↗
Kenny Adessky

Resignation Previously Director and corporate secretary

Hapbee ↗
Bally Singh

Appointment Board Member

Product launches

Products, platforms and features in the recorded window

Improved simplified web experience

Website

FlexFit 3® smart adjustable base (updated look and feel)

Bed base

Contract wins

3 recorded customer wins

Versus ↗

Customer: FDJ UnitedDigital marketing

CardioNet ↗

Customer: BIOTELCardiac clinical research services

CardioNet ↗

Customer: Agility Centralized Research ServicesMedical device and pharmaceutical industry services

Workforce actions

3 companies with reported reductions

Fitbit ↗

110 roleslower demand

Somatix ↗

25 rolescost reduction

Cala Health ↗

107 rolescost reduction

Litigation

4 tracked suits

Company
cloud v Bert Bell/Pete Rozelle NFL

disability benefits under NFL Player Retirement PlanCivil · Appeal

Company
chronos v Infrastructure Leasing and Financial Services Ltd

enforcement of purchase bid and contractual considerationCivil · Ongoing

Earnings pulse

Reported company results in the recorded window.

10companies
84period observations
21.4%median reported growth

Median across 76 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
Stravathe breakaway2026-03-31Not stated in snapshot
Stravarunna2026-03-31Not stated in snapshot
Travis KelceSleep Number ↗Announced2026-01-29Not stated in snapshot
googleFitbit ↗Completed2026-01-14$2.1B
2PointZero GroupWhoop ↗Announced2025-12-18Not stated in snapshot
corvexMovano Health ↗Announced2025-12-01Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

5,819 postings in the preceding 12 months. The full 8,339-posting snapshot covers 135 employers.

Expand panel +

Most advertised job titles

Assistant Manager1,500
General Manager631
Field Sales Representative527
Sales Representative296
Cook264
Regional Sales Associate223
0 internship postings

72 tracked postings mention remote work.

The seniority mix

3,883 postings specify a level.

unspecified
4,456
manager
3,236
senior
414
lead
146
entry
55
intern
32

Skills employers mention

Top skills across 8,339 tracked postings in the available jobs snapshot.

Accounting
124
Computer Skills
123
Apps
33
Gcp
30
Point Of Sale Technology
28
Typescript
28
Ipads
28
Sql
28
React
27
Crm
26
ADVERTISED PAY$67.0K/ year

Median across 389 postings with pay data, expressed in USD.

Salary by seniority

manager$112.6K/ year106 postings
senior$128.0K/ year34 postings

Advertised posting medians do not describe all employees or roles.

THE PEOPLE BUILDING THE FIELD

Founders and leaders

1,038 founders and chief executives across 754 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

184 profiles with education records.

Massachusetts Institute of Technology
32
Harvard University
20
University of Pennsylvania
20
Stanford University
17
Harvard Business School
14
University of California (Berkeley)
14
Duke University
10
Columbia University
10

Prior employers

40 profiles with prior-work records.

Microsoft
8
Google
8
Intel
6
Apple
5
Facebook
5
Amazon
3
McKinsey
3
Morgan Stanley
3

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

220,321 articles in the measured 12-month window.

Expand panel +
220,321articles in the measured year
59,283articles in 2026Q1
71.8%positive tone in the latest complete year

News volume trends

Wearables coverage across United States · articles per complete quarter

023,96447,92971,89395,8572021Q2: 26,8182021Q22021Q3: 31,2842021Q4: 26,9282022Q1: 36,2562022Q2: 31,1662022Q22022Q3: 32,0322022Q4: 35,8322023Q1: 42,1212023Q2: 54,2922023Q22023Q3: 46,8682023Q4: 53,1632024Q1: 57,7732024Q2: 53,5472024Q22024Q3: 57,7792024Q4: 54,4652025Q1: 83,3542025Q2: 48,4252025Q22025Q3: 62,4572025Q4: 49,9572026Q1: 59,2832026Q1
View quarterly article counts
QuarterArticles
2021Q226,818
2021Q331,284
2021Q426,928
2022Q136,256
2022Q231,166
2022Q332,032
2022Q435,832
2023Q142,121
2023Q254,292
2023Q346,868
2023Q453,163
2024Q157,773
2024Q253,547
2024Q357,779
2024Q454,465
2025Q183,354
2025Q248,425
2025Q362,457
2025Q449,957
2026Q159,283

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
70,710 positive · 709 neutral · 19,924 negative
2022
100,518 positive · 1,066 neutral · 33,631 negative
2023
146,065 positive · 1,442 neutral · 48,848 negative
2024
171,229 positive · 1,204 neutral · 51,045 negative
2025
175,318 positive · 1,492 neutral · 67,229 negative

Leading coverage topics

Wearables coverage across United States · ranked by full-period article count.

Artificial Intelligence Advancements32,181 articles in the full recorded period
12,544 recent · 8,935 prior
New Product Launches And Innovations16,493 articles in the full recorded period
5,407 recent · 3,887 prior
Technology Adoption And Digital Transformation14,440 articles in the full recorded period
4,609 recent · 3,480 prior
Semiconductor Industry Updates13,538 articles in the full recorded period
5,147 recent · 3,401 prior
Latest Gadgets And Consumer Electronics12,557 articles in the full recorded period
3,473 recent · 2,524 prior
Strategic Partnerships And Collaborations12,381 articles in the full recorded period
4,031 recent · 2,873 prior
Tech Policy And Government Regulations11,069 articles in the full recorded period
2,993 recent · 2,974 prior
Mobile Operating Systems11,050 articles in the full recorded period
2,902 recent · 2,289 prior
Cybersecurity Threats And Solutions10,115 articles in the full recorded period
2,800 recent · 2,370 prior
Ethical Considerations In Ai Development9,454 articles in the full recorded period
3,586 recent · 2,391 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Wearables coverage across United States

KeywordRecentPriorChange
cloud infrastructure1,65094375%
ai copyright issues812376116%
green data centers80150858%
new gadgets69446450%
ai liability668229192%
tablet60942244%
h-1b visa520471006%
ip litigation504441045%
smart glasses469172173%
tech legislation46232741%
drone defense587982-40%
faa drone rules401899-55%
drone airspace rules391883-56%
anti-drone system479748-36%
political reporting238734-68%

Event and signal lenses

Wearables coverage across United States

All complete annual cohorts shown
Rising

Regulatory Risk

199,843 classified articles

ai regulation compliance, responsible ai, ai research

62.1% critical · 37.6% positive
Rising

Funding Momentum

41,385 classified articles

ai infrastructure financing, neural network ventures, ai chip investments

52.6% critical · 56.3% positive
Rising

Growth

112,270 classified articles

ai hardware, dc fast-charging deployment, ai research

40.3% critical · 51.6% positive

Wearables coverage across United States. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Wearables research is working on

2,695 papers in the recorded india scope.

Expand panel +
2,695papers
12,507worldwide comparison pool
2,695India-affiliated papers

Research orientation

Promising
1,012
Descriptive
432
Problem-identifying
376
Cautionary
317
Comparative
278
Breakthrough
236
Critical
44

Contribution mix

Empirical
1,667
Methods-led
467
Reviews
383
Position pieces
176
Theoretical
2

Tone counts: 2,355 positive · 228 neutral · 112 negative.

Common problems researchers identify
420 papers · 15.6% of this field
  • Continuous glucose monitoring238 papers
  • Diabetes mellitus234 papers
  • Glycemic114 papers
  • Hypoglycemia87 papers
  • Intensive care medicine77 papers
  • Blood Glucose Self-Monitoring69 papers
  • Type 1 diabetes69 papers
  • Type 2 diabetes52 papers

Landmark: Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Cautions
317 papers · 11.8% of this field
  • Continuous glucose monitoring211 papers
  • Diabetes mellitus146 papers
  • Glycemic103 papers
  • Hypoglycemia71 papers
  • Type 1 diabetes63 papers
  • Blood Glucose Self-Monitoring50 papers
  • Type 2 diabetes48 papers
  • Insulin33 papers

Landmark: The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes

Opportunities
1,248 papers · 46.3% of this field
  • Continuous glucose monitoring749 papers
  • Diabetes mellitus532 papers
  • Glycemic360 papers
  • Hypoglycemia277 papers
  • Type 1 diabetes234 papers
  • Type 2 diabetes187 papers
  • Insulin146 papers
  • Blood Glucose Self-Monitoring129 papers

Landmark: Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes

Leading institutions

Close Concerns
6,414
Breakthrough T1D
6,378
Jaeb Center for Health Research
5,339
Harvard University
4,751
American Diabetes Association
4,423
Joslin Diabetes Center
3,826

Leading researchers

Richard M. Bergenstal
8,277
Roy W. Beck
6,764
Tadej Battelino
5,881
Thomas Danne
5,806
Stephanie A. Amiel
3,651
Kelly L. Close
2,794
Timothy S. Bailey
2,726
Boris Kovatchev
2,152

Highly cited breakthrough-labelled papers

  • Microneedle-Based Detection of Ketone Bodies along with Glucose and Lactate: Toward Real-Time Continuous Interstitial Fluid Monitoring of Diabetic Ket261 citations
  • Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes193 citations
  • Touch-Based Fingertip Blood-Free Reliable Glucose Monitoring: Personalized Data Processing for Predicting Blood Glucose Concentrations190 citations
  • Porous Enzymatic Membrane for Nanotextured Glucose Sweat Sensors with High Stability toward Reliable Noninvasive Health Monitoring179 citations
  • Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experie179 citations

Common problems researchers identify

405 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

CGM in Critical CareCommon problems researchers identify · 01

CGM in Critical Care

124 papers

30.6% of this theme group

Researchers highlight challenges of using continuous glucose monitors for intensive care and emergency diabetes management.

Continuous glucose monitoring (118) · Intensive care medicine (52) · Diabetes mellitus (57) · Emergency medicine (9)

Continuous Glucose Sensing: Future Technology Developments

Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations

View research history
YearShare index
20222908.6
20232901.3
20243445.3
20252528.4
Barriers to CGM AdoptionCommon problems researchers identify · 02

Barriers to CGM Adoption

91 papers

22.5% of this theme group

Studies point to practical and perceptual obstacles preventing widespread continuous glucose monitor use in diabetes.

Continuous glucose monitoring (69) · Type 1 diabetes (38) · Diabetes mellitus (57) · Type 2 diabetes (24)

Perceived Burdens and Benefits Associated With Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan

Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives

View research history
YearShare index
2022926.4
2023926.3
2024937.2
20251005.4
Errors in Blood Glucose Self‑MonitoringCommon problems researchers identify · 03

Errors in Blood Glucose Self‑Monitoring

68 papers

16.8% of this theme group

Works examine sources of inaccuracy and user difficulties in traditional blood glucose meter testing.

Blood Glucose Self-Monitoring (47) · Blood glucose monitoring (21) · Glucose meter (13) · Diabetes mellitus (49)

Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement

Understanding Self-Monitoring of Blood Glucose Among Individuals With Type 1 and Type 2 Diabetes

View research history
YearShare index
202212.2
202313.1
202412.9
202517.8
Integration of Wearable Diabetes TechCommon problems researchers identify · 04

Integration of Wearable Diabetes Tech

54 papers

13.3% of this theme group

Papers discuss the interplay between wearable computers, insulin delivery, and continuous glucose monitoring.

Diabetes mellitus (40) · Wearable computer (6) · Insulin delivery (7) · Continuous glucose monitoring (25)

Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?

View research history
YearShare index
202217.0
202318.6
202420.2
202531.8
Hypoglycemia Risks in Type 1 DiabetesCommon problems researchers identify · 05

Hypoglycemia Risks in Type 1 Diabetes

43 papers

10.6% of this theme group

Research flags severe low‑glucose events and the need for better prevention strategies.

Diabetes mellitus (36) · Hypoglycemia (23) · Type 1 diabetes (22) · Glycemic (21)

Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention

Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study

View research history
YearShare index
2022411.4
2023417.0
2024380.7
2025484.7
Glycemic Control in Critical IllnessCommon problems researchers identify · 06

Glycemic Control in Critical Illness

16 papers

4.0% of this theme group

Authors raise concerns about managing blood sugar and preventing hypoglycemia in ICU patients.

Critically ill (10) · Glycemic (14) · Hypoglycemia (13) · Intensive care unit (6)

Metabolic Management during Critical Illness: Glycemic Control in the ICU

Glucose Management Technologies for the Critically Ill

View research history
YearShare index
2022355.7
2023348.3
2024321.9
2025447.4
CGM During PregnancyCommon problems researchers identify · 07

CGM During Pregnancy

9 papers

2.2% of this theme group

Studies note specific challenges of continuous glucose monitoring for gestational and pregnant diabetes patients.

Pregnancy (6) · Gestational diabetes (3) · Gestation (2) · Diabetes in pregnancy (2)

Continuous Glucose Monitoring Metrics and Birth Weight: Informing Management of Type 1 Diabetes Throughout Pregnancy

Improving postpartum glucose monitoring in women with gestational diabetes

View research history
YearShare index
20222541.7
20232489.1
20242263.2
20252146.1

Cautions

312 papers · 6 recurring themes
6 cards

Swipe or scroll horizontally to browse.

CGM Across Diabetes TypesCautions · 01

CGM Across Diabetes Types

112 papers

35.9% of this theme group

Cautionary analyses evaluate continuous glucose monitoring benefits and limitations for both type 1 and type 2 patients.

Diabetes mellitus (87) · Type 2 diabetes (42) · Continuous glucose monitoring (87) · Type 1 diabetes (46)

Real-World Studies Support Use of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes Independently of Treatment Regimen

Diabetes: the role of continuous glucose monitoring

View research history
YearShare index
2022926.4
2023926.3
2024937.2
20251005.4
Hospital CGM ImplementationCautions · 02

Hospital CGM Implementation

89 papers

28.5% of this theme group

Works advise careful assessment of practical and safety issues when deploying continuous glucose monitors in clinical settings.

Continuous glucose monitoring (83) · Intensive care medicine (26) · Intensive care unit (7) · Biomedical engineering (7)

Clinical Need for Continuous Glucose Monitoring in the Hospital

Real-Time Continuous Glucose Monitoring in the Clinical Setting: The Good, the Bad, and the Practical

View research history
YearShare index
20222843.9
20232843.5
20243406.5
20252545.2
Real‑Time CGM and Insulin TherapyCautions · 03

Real‑Time CGM and Insulin Therapy

46 papers

14.7% of this theme group

Research cautions about interpreting episodic CGM data and its impact on insulin treatment decisions.

Glycemic (22) · Diabetes mellitus (27) · Hypoglycemia (17) · Insulin (14)

Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

Associations Between Improved Glucose Control and Patient-Reported Outcomes After Initiation of Insulin Pump Therapy in Patients with Type 2

View research history
YearShare index
2022661.9
2023655.5
2024544.9
2025626.1
Accuracy of Self‑Monitored GlucoseCautions · 04

Accuracy of Self‑Monitored Glucose

30 papers

9.6% of this theme group

Papers stress the clinical consequences of measurement errors in traditional blood glucose monitoring.

Diabetes mellitus (17) · Blood Glucose Self-Monitoring (10) · Blood glucose monitoring (5) · Venous blood (2)

The Future of Self-Monitored Blood Glucose: Mean Blood Glucose Versus Glycosylated Hemoglobin

Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study

View research history
YearShare index
202216.8
202318.1
202415.0
202520.9
CGM in Gestational DiabetesCautions · 05

CGM in Gestational Diabetes

22 papers

7.1% of this theme group

Authors call for careful evaluation of continuous glucose monitoring utility and safety during pregnancy.

Pregnancy (12) · Glycemic (14) · Gestational diabetes (5) · Continuous glucose monitoring (13)

Application and Utility of Continuous Glucose Monitoring in Pregnancy: A Systematic Review

CGM, Pregnancy, and Remote Monitoring

View research history
YearShare index
20222714.5
20232665.4
20242412.1
20252378.4
Artificial Pancreas SafetyCautions · 06

Artificial Pancreas Safety

13 papers

4.2% of this theme group

Studies highlight potential hazards and data‑stream quirks affecting closed‑loop insulin delivery systems.

Artificial pancreas (8) · Total pancreatectomy (3) · Pancreatectomy (3) · Closed loop (3)

Peculiarities of the Continuous Glucose Monitoring Data Stream and Their Impact on Developing Closed-Loop Control Technology

A Review of Safety and Hazards Associated With the Artificial Pancreas

View research history
YearShare index
20228.5
202310.3
20246.8
20258.6

Opportunities

1,215 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Improving Glycemic Control with CGMOpportunities · 01

Improving Glycemic Control with CGM

321 papers

26.4% of this theme group

Research showcases how advanced continuous glucose monitoring can enhance overall blood‑sugar management.

Continuous glucose monitoring (283) · Intensive care medicine (53) · Diabetes mellitus (134) · Glycemic (97)

Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm

Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of

View research history
YearShare index
20222944.4
20232954.1
20243500.4
20252705.7
Long‑Term Benefits of CGMOpportunities · 02

Long‑Term Benefits of CGM

321 papers

26.4% of this theme group

Evidence suggests continuous glucose monitoring leads to sustained improvements in HbA1c and glucose variability.

Type 2 diabetes (148) · Continuous glucose monitoring (267) · Diabetes mellitus (239) · Type 1 diabetes (137)

Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in

Use of Continuous Glucose Monitoring in Patients with Type 1 Diabetes

View research history
YearShare index
2022926.4
2023926.3
2024937.2
20251005.4
Predictive Models for HypoglycemiaOpportunities · 03

Predictive Models for Hypoglycemia

202 papers

16.6% of this theme group

Works explore machine‑learning approaches to forecast low‑glucose events and guide preventive actions.

Hypoglycemia (87) · Diabetes mellitus (121) · Glycemic (88) · Postprandial (26)

Development of a Neural Network for Prediction of Glucose Concentration in Type 1 Diabetes Patients

Prediction and Prevention of Treatment-Related Inpatient Hypoglycemia

View research history
YearShare index
2022284.4
2023282.0
2024238.9
2025332.2
Next‑Generation BiosensorsOpportunities · 04

Next‑Generation Biosensors

158 papers

13.0% of this theme group

Papers present novel nanotech and wearable sensor designs for non‑invasive glucose detection.

Biosensor (24) · Biomedical engineering (35) · Nanotechnology (21) · Continuous glucose monitoring (104)

Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review

Self-monitoring of tear glucose: the development of a tear based glucose sensor as an alternative to self-monitoring of blood glucose

View research history
YearShare index
202247.6
202349.5
202457.3
202540.9
Integrated Insulin Pump & CGM SystemsOpportunities · 05

Integrated Insulin Pump & CGM Systems

109 papers

9.0% of this theme group

Studies highlight combined pump and monitoring solutions that automate insulin dosing and reduce variability.

Insulin pump (35) · Insulin (48) · Diabetes mellitus (79) · Type 1 diabetes (53)

Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variabilit

View research history
YearShare index
2022674.8
2023667.0
2024574.2
2025585.3
Artificial Pancreas AdvancesOpportunities · 06

Artificial Pancreas Advances

58 papers

4.8% of this theme group

Research details closed‑loop insulin delivery platforms that improve safety and reduce hypoglycemia risk.

Artificial pancreas (54) · Insulin delivery (14) · Insulin (21) · Hypoglycemia (25)

Automated closed-loop control of diabetes: the artificial pancreas

Design of the Health Monitoring System for the Artificial Pancreas: Low Glucose Prediction Module

View research history
YearShare index
2022521.4
2023511.0
2024414.4
2025408.2
CGM for Maternal‑Fetal HealthOpportunities · 07

CGM for Maternal‑Fetal Health

46 papers

3.8% of this theme group

Investigations focus on using continuous glucose data to inform pregnancy outcomes and infant growth.

Pregnancy (23) · Gestational diabetes (12) · Obstetrics (7) · Continuous glucose monitoring (35)

Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes

A Standard Approach to Continuous Glucose Monitor Data in Pregnancy for the Study of Fetal Growth and Infant Outcomes

View research history
YearShare index
20222558.0
20232505.5
20242282.3
20252158.6

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Promising37.6%37.0%
Descriptive16.0%17.4%
Problem-identifying14.0%9.6%
Cautionary11.8%4.6%
Comparative10.3%3.7%
Breakthrough8.8%26.7%
Critical1.6%0.9%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceDevelopment of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol100.38%4 (40.0%)0.36%
Bias & fairnessDiscrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes20.08%2 (100.0%)0.02%
Energy & datacenter footprint00.0%0 (%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Hardware, e-waste & supply chain00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Safety & misuse00.0%0 (%)0.02%
Concentration of compute power00.0%0 (%)0.01%

Institution and researcher rankings use citations to their covered work. Research scope: United States. This may be broader than the company geography.

DEMAND, SUPPLY & PLACE

Where demand signals run ahead of mapped supply — the United States

Compare demand signals in the United States’s newsflow with the wearables categories mapped to each signal.

Expand panel +
HOW TO READ THE GAP

Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.

The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.

COMPARISON PERIOD2025-07-01 to 2026-07-01Against 2024-07-01 to 2025-07-01Explore the signals ↓

The opportunity, in one view

Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.

Swipe horizontally to compare all columns →

8 the United States demand signals compared with mapped wearables supply
Signal familySignal percentileSupply percentileRelative gapGap (points)Signal share vs prior year
Cancer burden ↗Disease Burden35.70.0+35.7+2.5%
Air pollution ↗Environmental Driver21.433.3-11.9-18.3%
Ageing & elder care ↗Disease Burden28.666.7-38.1-43.4%
Diabetes, hypertension & cardiac burden ↗Disease Burden21.4100.0-78.6+21.4%
Mental health ↗Disease Burden78.6No matching category+63.1%
Infectious outbreaks ↗Disease Burden35.7No matching category+45.9%
Maternal & child health ↗Disease Burden92.9No matching category+110.1%
Layoffs & income shocks ↗Spending Pressure85.7No matching category+57.7%

Showing all 8 signals. Select a family for its history and mapped categories.

Where the signals are loudest

All 12 city readings for these demand families in the comparison geography. the United States is highlighted.

Mentions per 10,000 articles

Each city’s reading is a share of its own coverage.

Kentucky172.3

Maternal & child health · Mental health · Layoffs & income shocks

Delaware159.7

Maternal & child health · Ageing & elder care · Cancer burden

Indiana137.6

Maternal & child health · Mental health · Layoffs & income shocks

Maryland130.4

Maternal & child health · Mental health · Layoffs & income shocks

Connecticut124.9

Mental health · Maternal & child health · Ageing & elder care

South Carolina124.2

Maternal & child health · Layoffs & income shocks · Infectious outbreaks

Iowa121.1

Maternal & child health · Layoffs & income shocks · Mental health

Colorado120.9

Mental health · Maternal & child health · Air pollution

Wisconsin120.9

Maternal & child health · Mental health · Ageing & elder care

Louisiana120.9

Maternal & child health · Mental health · Layoffs & income shocks

Tennessee116.2

Layoffs & income shocks · Maternal & child health · Mental health

North Carolina114.7

Mental health · Maternal & child health · Layoffs & income shocks

Inside the leading signals

Open any signal for its quarterly history
DISEASE BURDENCancer burden+35.7percentile-point gap
THE OPERATING HYPOTHESIS

Cancer burden can pull screening, diagnostics and oncology capacity demand.

7.52mentions per 10,000 articles+2.5%share change vs prior year

Mapped wearables categories

  • Life Sciences301

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

0369122024Q3: 62024Q32024Q4: 82024Q42025Q1: 62025Q12025Q2: 82025Q22025Q3: 62025Q32025Q4: 102025Q42026Q1: 72026Q12026Q2: 82026Q2
View quarterly signal counts
Cancer burden in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q310876.38
2024Q415518.75
2025Q116166.46
2025Q213068.19
2025Q316466.04
2025Q4123810.26
2026Q111147.72
2026Q26248.11

Where this signal concentrates in the comparison geography

Delaware15.3 / 10,000
Missouri14.4 / 10,000
Maryland12.9 / 10,000
ENVIRONMENTAL DRIVERAir pollution-11.9percentile-point gap
THE OPERATING HYPOTHESIS

Sustained air-quality stress can pull respiratory and cardiac care demand with it.

6.47mentions per 10,000 articles-18.3%share change vs prior year

Mapped wearables categories

  • Chronic Disease Management395

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

0369112024Q3: 62024Q32024Q4: 82024Q42025Q1: 72025Q12025Q2: 92025Q22025Q3: 52025Q32025Q4: 52025Q42026Q1: 72026Q12026Q2: 82026Q2
View quarterly signal counts
Air pollution in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q310756.31
2024Q414458.15
2025Q119067.62
2025Q215729.86
2025Q316265.97
2025Q46465.35
2026Q110767.45
2026Q26278.14

Where this signal concentrates in the comparison geography

Louisiana16.4 / 10,000
Delaware14.5 / 10,000
Colorado14.5 / 10,000
DISEASE BURDENAgeing & elder care-38.1percentile-point gap
THE OPERATING HYPOTHESIS

An ageing base can shift demand toward geriatric, home and chronic care.

7.85mentions per 10,000 articles-43.4%share change vs prior year

Mapped wearables categories

  • Chronic Disease Management395
  • Hospital At Home326

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

051015202024Q3: 122024Q32024Q4: 172024Q42025Q1: 122025Q12025Q2: 132025Q22025Q3: 62025Q32025Q4: 82025Q42026Q1: 82026Q12026Q2: 82026Q2
View quarterly signal counts
Ageing & elder care in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q3209212.27
2024Q4302717.07
2025Q1316612.65
2025Q2222213.94
2025Q318016.61
2025Q410428.63
2026Q112948.96
2026Q26898.95

Where this signal concentrates in the comparison geography

Delaware24.3 / 10,000
Connecticut23.5 / 10,000
Indiana16.4 / 10,000
DISEASE BURDENDiabetes, hypertension & cardiac burden-78.6percentile-point gap
THE OPERATING HYPOTHESIS

Chronic cardiometabolic burden can turn into decades of management demand per patient.

4.5mentions per 10,000 articles+21.4%share change vs prior year

Mapped wearables categories

  • Medical Devices670
  • Chronic Disease Management395

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

024682024Q3: 32024Q32024Q4: 32024Q42025Q1: 42025Q12025Q2: 42025Q22025Q3: 32025Q32025Q4: 62025Q42026Q1: 42026Q12026Q2: 52026Q2
View quarterly signal counts
Diabetes, hypertension & cardiac burden in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q35553.26
2024Q45393.04
2025Q110174.06
2025Q26934.35
2025Q39083.33
2025Q48056.67
2026Q16374.41
2026Q24135.36

Where this signal concentrates in the comparison geography

Connecticut11.1 / 10,000
Missouri8.4 / 10,000
Mississippi7.2 / 10,000
DISEASE BURDENMental healthsupply not mapped
THE OPERATING HYPOTHESIS

Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.

14.86mentions per 10,000 articles+63.1%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

05914192024Q3: 92024Q32024Q4: 102024Q42025Q1: 72025Q12025Q2: 92025Q22025Q3: 162025Q32025Q4: 122025Q42026Q1: 152026Q12026Q2: 122026Q2
View quarterly signal counts
Mental health in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q316879.9
2024Q4183210.33
2025Q119197.67
2025Q214649.19
2025Q3438416.09
2025Q4152112.6
2026Q1229315.88
2026Q293512.15

Where this signal concentrates in the comparison geography

Colorado42.7 / 10,000
Mississippi32.6 / 10,000
Connecticut29.9 / 10,000
DISEASE BURDENInfectious outbreakssupply not mapped
THE OPERATING HYPOTHESIS

Outbreak pressure can pull testing, surveillance and rapid-care demand at short notice.

6.38mentions per 10,000 articles+45.9%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

0368112024Q3: 32024Q32024Q4: 42024Q42025Q1: 32025Q12025Q2: 52025Q22025Q3: 92025Q32025Q4: 32025Q42026Q1: 32026Q12026Q2: 42026Q2
View quarterly signal counts
Infectious outbreaks in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q36733.95
2024Q48004.51
2025Q19813.92
2025Q28605.4
2025Q326509.72
2025Q44653.85
2026Q14403.05
2026Q23684.78

Where this signal concentrates in the comparison geography

Kentucky19.4 / 10,000
South Carolina14.6 / 10,000
Louisiana14.3 / 10,000
DISEASE BURDENMaternal & child healthsupply not mapped
THE OPERATING HYPOTHESIS

Maternal and child burden can pull immunisation, nutrition and pediatric care demand.

18.23mentions per 10,000 articles+110.1%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

081725342024Q3: 72024Q32024Q4: 72024Q42025Q1: 72025Q12025Q2: 112025Q22025Q3: 292025Q32025Q4: 92025Q42026Q1: 72026Q12026Q2: 112026Q2
View quarterly signal counts
Maternal & child health in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q313337.82
2024Q414147.97
2025Q119627.84
2025Q2186411.69
2025Q3800929.39
2025Q411689.68
2026Q111097.68
2026Q291911.94

Where this signal concentrates in the comparison geography

Delaware62.8 / 10,000
Kentucky61.4 / 10,000
South Carolina60.0 / 10,000
SPENDING PRESSURELayoffs & income shockssupply not mapped
THE OPERATING HYPOTHESIS

Layoff cycles can pull discretionary spend back toward value offerings.

24.69mentions per 10,000 articles+57.7%share change vs prior year

Mapped wearables categories

This signal has no matching category in the page’s wearables market map, so no supply percentile or gap is assigned.

Quarterly share of the United States coverage

Mentions per 10,000 articles · zero baseline

091827362024Q3: 152024Q32024Q4: 142024Q42025Q1: 132025Q12025Q2: 192025Q22025Q3: 242025Q32025Q4: 312025Q42026Q1: 192026Q12026Q2: 242026Q2
View quarterly signal counts
Layoffs & income shocks in the United States coverage
QuarterMentionsPer 10,000 articles
2024Q3269215.79
2024Q4265714.98
2025Q1345713.81
2025Q2305519.17
2025Q3668724.54
2025Q4376131.16
2026Q1284319.69
2026Q2188524.49

Where this signal concentrates in the comparison geography

Tennessee44.9 / 10,000
Arkansas41.1 / 10,000
Iowa26.8 / 10,000
RESEARCH & CHANGING CONVERSATIONS

Related research and changing coverage

the United States wearables coverage

Expand panel +
RESEARCH CONTEXT · 2017

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Hypertension

7,315 citations in the snapshot

RESEARCH CONTEXT · 2019

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Circulation

6,114 citations in the snapshot

RESEARCH CONTEXT · 2019

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Circulation

4,494 citations in the snapshot

RESEARCH CONTEXT · 2019

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Circulation

4,422 citations in the snapshot

What is growing in this coverage

the United States coverage of this page's demand families

KeywordRecent articlesPrior articlesShare change
post-covid complications1,1031051194.7%
last-mile vaccine delivery14523677.0%
epidemic death tolls31353627.8%
snow rescue19936581.3%
disease outbreak deaths700152467.6%
contagion mortality rates22049453.3%

Share changes describe coverage in the stated comparison periods, not search demand or market size.

GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Wearables in the United States: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 30 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon